Skip Navigation


BJA Advance Access originally published online on April 27, 2007
British Journal of Anaesthesia 2007 98(6):722-727; doi:10.1093/bja/aem083
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
98/6/722    most recent
aem083v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Baumert, J.-H.
Right arrow Articles by Rossaint, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baumert, J.-H.
Right arrow Articles by Rossaint, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Board of Management and Trustees of the British Journal of Anaesthesia 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Autonomic cardiac control with xenon anaesthesia in patients at cardiovascular risk

J.-H. Baumert*, M. Hein, K. E. Hecker, S. Satlow, J. Schnoor and R. Rossaint

Klinik fuer Anaesthesiologie, Universitaetsklinikum Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany

* Corresponding author: Department of Anesthesiology, UMC St. Radboud, Geert Grooteplein 10, Postbus 9101, Nijmegen 6500 HB, The Netherlands. E-mail: jan.baumert{at}googlemail.com

Background: The cardiovascular stability found with xenon anaesthesia may be caused by absence of circulatory depression. Xenon may also act directly on autonomic cardiovascular control.

Methods: In a prospective, randomized design, 26 patients (ASA class III and IV) with increased cardiac risk were anaesthetized for elective non-cardiac surgery with either xenon (n = 13) or propofol (n = 13), each combined with remifentanil. From intraoperative Holter ECG, 5-min intervals of stable sinus rhythm were analysed at baseline anaesthesia with etomidate/remifentanil, and after 30 and 60 min of propofol or xenon anaesthesia. Target criteria were total power and ratio of low to high frequency power of the heart rate (HR) power spectrum between 0.003 and 0.4 Hz, indicating global activity and sympatho-vagal balance of autonomic modulation of HR.

Results: When compared with baseline, total power decreased with propofol from 8.6 (1.6) to 7.1 (0.5) and to 7.8 (1.1) ms2 at 30 and 60 min, respectively, [mean (SD) of logarithmic transform] and was unchanged with xenon (P = 0.02; ANOVA). The low/high frequency power ratio changed from 3.0 (3.5) to 4.3 (4.3) and 4.1 (6.2), respectively, with xenon and from 3.9 (3.6) to 1.8 (1.5) and 1.8 (0.8) with propofol (P = 0.04; generalized linear model test). Mean arterial pressure was significantly higher with xenon throughout (P < 0.001; ANOVA).

Conclusions: Propofol caused a decrease in arterial pressure as well as autonomic HR modulation, but xenon did not. The higher arterial pressure with xenon anaesthesia may be explained by less suppression of sympatho-vagal balance.

Keywords: anaesthetic techniques, inhalation; anaesthetics gases, xenon; anaesthetics i.v., propofol; complications, hypotension; sympathetic nervous system


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Br J AnaesthHome page
J.-H. Baumert, M. Hein, K. E. Hecker, S. Satlow, P. Neef, and R. Rossaint
Xenon or propofol anaesthesia for patients at cardiovascular risk in non-cardiac surgery
Br. J. Anaesth., May 1, 2008; 100(5): 605 - 611.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.